Loading...
Cefpodoxime Dry Syp
A synergistic, broad-spectrum pediatric antibiotic. EXLLA-CV combines the advanced bactericidal power of Cefpodoxime with the protective shield of Clavulanic Acid, specifically engineered to cure resistant respiratory, urinary, and ear infections in children.
A synergistic, broad-spectrum pediatric antibiotic. EXLLA-CV combines the advanced bactericidal power of Cefpodoxime with the protective shield of Clavulanic Acid, specifically engineered to cure resistant respiratory, urinary, and ear infections in children.
Cefpodoxime Proxetil is a potent third-generation cephalosporin. When paired with Clavulanic Acid, its efficacy is dramatically increased because the Clavulanate "disarms" the bacteria's defense enzymes, allowing the Cefpodoxime to penetrate and destroy the bacterial cell wall without interference.
Many common pathogens have developed resistance to basic Cefixime or Cefpodoxime. EXLLA-CV is the "Specialist's Choice" for recurrent infections or when a child has not responded to first-line antibiotic treatments.
This combination offers excellent coverage against both Gram-positi...
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
